Key Quantitative Figures and Allotment Details

  • The Compensation Committee approved the allotment of 1,52,000 equity shares of face value ₹10 each, fully paid-up.
  • This allotment comprises two tranches:
  • 50,000 shares allotted under the RML Employee Stock Option Plan II – 2023 (RML ESOP II 2023).
  • 1,02,000 shares allotted under the RML Employee Stock Option Plan – 2024 (RML ESOP 2024).
  • The total money realized from the exercise of these options is ₹76,00,000 (₹25,00,000 from RML ESOP II 2023 and ₹51,00,000 from RML ESOP 2024).
  • The exercise price for options under both plans was ₹50 per share, implying a premium of ₹40 per share.

Dates of Action

  • The Compensation Committee meeting approving the allotment was held on August 24, 2026.
  • The date of issue of the shares is August 24, 2026.

Capital Structure Impact

  • Consequent to this allotment, the issued and paid-up equity share capital of the company has increased from ₹7,62,40,470 (76,24,047 shares) to ₹7,72,60,470.
  • The total number of issued shares now stands at 77,26,047 equity shares of ₹10 each.
  • The newly allotted shares shall rank pari-passu with the existing equity shares of the company in all respects from the date of allotment and are not subject to any lock-in.

Share Identification Details

  • For RML ESOP II 2023 (50,000 shares): Distinctive numbers from 7574048 to 7624047. ISIN: INE649C01012.
  • For RML ESOP 2024 (1,02,000 shares): Distinctive numbers from 7624048 to 7726047. ISIN: INE649C01012.

ESOP Plan Details

RML ESOP II 2023:

  • Total options granted: 5,00,000 to 1 eligible employee.
  • Vesting period: 1 year from the grant date.
  • Exercise period: 4 years from the respective vesting date.

RML ESOP 2024:

  • Total options granted: 40,00,000.
  • Vesting period: 1 year from the grant date.
  • Exercise period: 4 years from the respective vesting date.

Regulatory References and Annexures

The disclosure is made under:

  • Regulation 30 of the SEBI (LODR) Regulations, 2015, read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015 (Annexure-I).
  • Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 (Annexure-II).
  • The initial statements for the plans were filed with the exchange on August 11, 2023 (for ESOP II 2023) and November 26, 2024 (for ESOP 2024).

Parties Involved

  • The disclosure is signed by Vaishali Parkar Kumar, Managing Director (DIN: 09159108), and Dharini Kadakia, Company Secretary (Membership No: A76992).
  • The plans are administered by the company's Compensation Committee.